Latest On Aduro Biotech, Inc (ADRO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-10-07 21:30 EST | Insider Trade | ERIC DOBMEIER has directly acquired 46,337 shares and currently holds 46,337 shares. | Buy |  |
| 2020-10-07 21:30 EST | Insider Trade | Tom Frohlich has directly acquired 153,398 shares and currently holds 153,398 shares. | Buy | |
| 2020-10-07 21:30 EST | Insider Trade | Davis Jerel has indirectly acquired of 2,433,099 shares. | Buy | |
| 2020-10-07 21:30 EST | Insider Trade | Davis Jerel has indirectly acquired of 722,247 shares. | Buy | |
| 2020-10-07 21:30 EST | Insider Trade | Davis Jerel has indirectly acquired of 4,733,023 shares. | Buy | |
| 2020-10-07 21:30 EST | Insider Trade | Davis Jerel has directly acquired 730,470 shares and currently holds 730,470 shares. | Buy | |
| 2020-10-07 21:30 EST | Insider Trade | SRINIVAS AKKARAJU has indirectly acquired of 3,168,388 shares. | Buy | |
| 2020-10-05 12:03 EST | Analyst Rating | The Analyst Target Price has increased from $3.75 to $18.75. | Buy | |
| 2020-10-03 16:01 EST | Stock Split | A stock split has occured on Oct 2, 2020 with a split factor of 1:5. | Neutral | |
| 2020-09-26 04:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 20:30 EST | Insider Trade | Celeste Ferber has directly disposed of 2,396 shares and currently holds 38,687 shares. | Sell | |
| 2020-09-17 20:30 EST | Insider Trade | Blaine Templeman has directly disposed of 12,369 shares and currently holds 121,916 shares. | Sell | |
| 2020-09-17 20:30 EST | Insider Trade | STEPHEN T ISAACS has directly disposed of 32,481 shares and currently holds 279,166 shares. | Sell | |
| 2020-08-11 16:15 EST | Insider Trade | Celeste Ferber has directly disposed of 7,951 shares and currently holds 41,083 shares. | Sell | |
| 2020-08-11 16:15 EST | Insider Trade | Blaine Templeman has directly disposed of 7,951 shares and currently holds 134,285 shares. | Sell | |
| 2020-08-11 16:15 EST | Insider Trade | Dimitry SA Nuyten has directly disposed of 3,538 shares and currently holds 8,462 shares. | Sell | |
| 2020-08-07 00:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 06:02 EST | News | Aduro Biotech EPS misses by $0.02, beats on revenue | N/A | |
| 2020-07-31 00:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 04:17 EST | News | Dosing underway in Aduro Bio's BION-1301 study for kidney disease | N/A | |
| 2020-06-04 08:02 EST | Analyst Rating | The Analyst Target Price has decreased from $6.88 to $3.75. | Neutral | |
| 2020-06-03 17:45 EST | Insider Trade | Blaine Templeman has directly acquired 22,500 shares and currently holds 142,236 shares. | Buy | |
| 2020-06-03 17:45 EST | Insider Trade | Dimitry SA Nuyten has directly acquired 10,000 shares and currently holds 12,000 shares. | Buy | |
| 2020-06-03 17:45 EST | Insider Trade | Ross Haghighat has directly acquired 34,124 shares and currently holds 121,246 shares. | Buy | |
| 2020-06-03 17:45 EST | Insider Trade | Celeste Ferber has directly acquired 22,500 shares and currently holds 49,034 shares. | Buy | |
| 2020-06-03 17:45 EST | Insider Trade | William G Kachioff has directly acquired 10,000 shares and currently holds 10,000 shares. | Buy | |
| 2020-06-03 08:02 EST | Analyst Rating | The Analyst Target Price has decreased from $7 to $6.88. | Neutral | |
| 2020-06-02 18:18 EST | News | Aduro Biotech and Chinook Therapeutics to merge | N/A | |
| 2020-06-02 08:02 EST | Earnings Estimate | An EPS average of -$0.18 is estimated for the quarter ending on September 30, 2020. | Sell | |
| 2020-05-06 20:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-05 00:11 EST | News | Aduro Biotech EPS beats by $0.05, beats on revenue | N/A | |
| 2020-05-03 08:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-10 16:01 EST | Analyst Rating | The Analyst Target Price has decreased from $7.33 to $7. | Neutral | |
| 2020-04-10 15:39 EST | News | Aduro Biotech EPS misses by $0.04, misses on revenue | N/A | |
| 2020-04-09 00:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-08 04:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-08 00:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-20 17:30 EST | Insider Trade | STEPHEN T ISAACS has directly disposed of 21,618 shares and currently holds 311,647 shares. | Sell | |
| 2020-03-20 17:30 EST | Insider Trade | William Mariner Greenman has directly acquired 19,835 shares and currently holds 19,835 shares. | Buy | |
| 2020-03-18 22:16 EST | News | Aduro: Float Like A Butterfly, Sting Like A Bee | N/A | |
| 2020-03-12 04:01 EST | Analyst Rating | The Analyst Target Price has increased from $7 to $7.33. | Buy | |
| 2020-03-12 04:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-10 04:01 EST | Earnings Estimate | An EPS average of -$0.62 is estimated for the 2021 year. | Sell | |
| 2020-03-10 04:01 EST | Earnings Estimate | An EPS average of -$0.17 is estimated for the quarter ending on June 30, 2020. | Buy | |
| 2020-02-27 19:01 EST | Earnings | Earnings have been released on February 28, 2019, with -$0.33 earnings per share. | Sell | |
| 2020-02-26 19:00 EST | Insider Trade | Elsas Andrea van has directly disposed of 6,823 shares and currently holds 438,367 shares. | Sell | |
| 2020-02-10 03:01 EST | Analyst Rating | The Analyst Target Price has increased from $6.75 to $7. | Buy | |
| 2020-02-03 03:01 EST | Analyst Rating | The Analyst Target Price has increased from $5.75 to $6.75. | Buy | |
| 2020-01-28 07:02 EST | Earnings | Earnings have been released on November 11, 2019, with -$0.26 earnings per share. | Sell | |
About Aduro Biotech, Inc (ADRO):
Aduro Biotech, Inc., an immunotherapy company, focuses on the discovery, development, and commercialization of therapies to harness the body's natural immune system for the treatment of patients with challenging diseases. The company is developing ADU-S100, which is in Phase I dose escalation clinical trial and Phase Ib dose escalation clinical trial in combination with spartalizumab to treat patients with advanced, metastatic treatment-refractory solid tumors; Phase I clinical trial in combination with ipilimumab for the treatment of relapsed and refractory melanoma; and Phase II clinical trial in combination with pembrolizumab, an approved anti-PD-1 antibody in patients with squamous cell carcinoma of the head and neck. It is also developing product candidates to prevent or control immune responses through the stimulator of interferon genes pathway. In addition, the company is developing BION-1301, a fully blocking humanized monoclonal anti-APRIL antibody that is in Phase I clinical trial for IgA nephropathy; and CD27, a co-stimulatory receptor, which is in preclinical studies expressed on different immune cells, such as T-lymphocytes and natural killer cells. It has collaboration agreements with Novartis Pharmaceuticals Corporation, Eli Lilly and Company, and Merck Sharp and Dohme B.V.; and license agreements with Karagen Pharmaceuticals, Inc., UC Berkeley, and Memorial Sloan Kettering Cancer Center. The company was formerly known as Oncologic, Inc. and changed its name to Aduro Biotech, Inc. in June 2008. Aduro Biotech, Inc. was founded in 2000 and is headquartered in Berkeley, California.
General
- Name Aduro Biotech, Inc
- Symbol ADRO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 69
- Last Split Factor1:5
- Last Split Date2020-10-02
- Fiscal Year EndDecember
- IPO Date2015-04-15
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.aduro.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 7.01
- Price/Book (Most Recent Quarter) 4.23
- Enterprise Value Revenue 2.09
View More
Financials
- Most Recent Quarter 2020-06-30
- Current Year EPS Estimate -$2.70
- Next Year EPS Estimate -$3.08
- Profit Margin -231%
- Operating Margin -240%
- Return on Assets -14%
- Return on Equity -87%
- Revenue 27.96 million
- Earnings Per Share -$1.15
- Revenue Per Share $1.73
- Gross Profit -48610000
- Quarterly Earnings Growth 14%
View More
Highlights
- Market Capitalization 236.61 million
- EBITDA -87830000
- PEG Ratio 0.06
- Analyst Target Price $18.75
- Book Value Per Share $2.88
View More
Share Statistics
- Shares Outstanding 16.21 million
- Shares Float 9.32 million
- % Held by Insiders 2984%
- % Held by Institutions 44.76%
- Shares Short 3.21 million
- Shares Short Prior Month 3.3 million
- Short Ratio 4.66
- Short % of Float 5%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 0.39
- 52 Week High $1185
- 52 Week Low $0.9
- 50 Day Moving Average 3.37
- 200 Day Moving Average 2.88
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
Aduro Biotech, Inc (ADRO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Aduro Biotech, Inc (ADRO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-08-03 | $N/A | -$1.05 | -$0.19 | -452.63% |
| 2020-03-31 | 2020-05-04 | $N/A | -$0.45 | -$0.13 | -246.15% |
| 2019-12-31 | 2020-03-09 | $3.63 million | -$1.20 | -$0.21 | -471.43% |
| 2019-09-30 | 2019-11-07 | $4.8 million | -$1.30 | -$0.23 | -465.22% |
| 2019-06-30 | 2019-08-01 | $4.89 million | -$1.15 | -$0.18 | -538.89% |
| 2019-03-31 | 2019-05-07 | $3.94 million | -$1.45 | -$0.19 | -663.16% |
| 2018-12-31 | 2019-02-27 | $2.76 million | -$0.33 | -$0.23 | -43.48% |
| 2018-09-30 | 2018-10-30 | $3.06 million | -$0.29 | -$0.31 | 6.45% |
| 2018-06-30 | 2018-08-01 | $2.64 million | -$0.31 | -$0.32 | 3.13% |
| 2018-03-31 | 2018-05-02 | $6.63 million | -$0.28 | -$0.35 | 20% |
| 2017-12-31 | 2018-03-01 | $3.76 million | -$0.34 | -$0.36 | 5.56% |
| 2017-09-30 | 2017-10-31 | $3.79 million | -$0.33 | -$0.36 | 8.33% |
| 2017-06-30 | 2017-08-02 | $5.92 million | -$0.27 | -$0.27 | 0% |
| 2017-03-31 | 2017-05-02 | $3.77 million | -$0.32 | -$0.39 | 17.95% |
| 2016-12-31 | 2017-03-01 | $3.88 million | -$0.44 | -$0.40 | -10% |
| 2016-09-30 | 2016-11-02 | $3.79 million | -$0.54 | -$0.47 | -14.89% |
| 2016-06-30 | 2016-08-03 | $38.98 million | $0.03 | -$0.06 | 150% |
| 2016-03-31 | 2016-05-02 | $4.03 million | -$0.45 | -$0.25 | -80% |
| 2015-12-31 | 2016-03-08 | $34.38 million | $0.04 | -$0.15 | 126.67% |
| 2015-09-30 | 2015-11-24 | $19.15 million | $0.01 | -$0.11 | 109.09% |
| 2015-06-30 | 2015-08-10 | $9.88 million | -$0.50 | $0.57 | -187.72% |
| 2015-03-31 | 2015-04-15 | $9.57 million | -$39.97 | -$0.08 | -49862.5% |
Aduro Biotech, Inc (ADRO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 15.83 million | N/A | 15.51 million | 16.88 million |
| Income Before Tax | N/A | N/A | -19.51 million | -23.2 million | -18.61 million |
| Selling General Administrative | N/A | N/A | 8.95 million | 8.68 million | 7.98 million |
| Gross Profit | N/A | N/A | -12.67 million | 4.8 million | -10.81 million |
| Ebit | N/A | N/A | -21.76 million | -19.53 million | -18.93 million |
| Operating Income | N/A | N/A | -21.76 million | -19.53 million | -18.93 million |
| Income Tax Expense | N/A | -5.67 million | -90000 | -2.25 million | -35000 |
| Total Revenue | N/A | N/A | 3.63 million | 4.8 million | 4.89 million |
| Cost of Revenue | N/A | N/A | 16.31 million | N/A | 15.7 million |
| Total Other Income Expense Net | N/A | N/A | 2.26 million | -3.67 million | 317000 |
| Net Income From Continuing Operations | N/A | N/A | -19.42 million | -20.95 million | -18.58 million |
| Net Income Applicable to Common Shares | -16.62 million | -7.58 million | -19.42 million | -20.95 million | -18.58 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | 28.01 million | -9.2 million | -17.63 million |
| Change to Liabilities | -4.23 million | -2.2 million | -4.5 million | -3.95 million | -4.14 million |
| Total Cash Flow from Investing Activities | -2.66 million | 42.6 million | 27.94 million | -10 million | -17.59 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | 47000 | 93000 | 352000 |
| Change to Operating Activities | -3.74 million | 2.89 million | -1.46 million | 1.14 million | 1.56 million |
| Change in Cash | N/A | N/A | 6.02 million | -25.96 million | -33.55 million |
| Total Cash from Operating Activities | -20.96 million | -7.87 million | -22.07 million | -15.85 million | -16.38 million |
| Depreciation | N/A | N/A | 1.19 million | 1.22 million | 1.23 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | -120000 | 1.14 million | -656000 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 2.75 million | 4.26 million | 2.23 million | 5.54 million | 4.21 million |
| Capital Expenditures | N/A | N/A | 77000 | 801000 | -42000 |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 225.91 million | 225.72 million | 231.27 million | 236.94 million |
| Total Stockholder Equity | N/A | 59.58 million | 65.6 million | 82.05 million | 101.05 million |
| Other Current Liabilities | N/A | N/A | 7.72 million | 16 million | 17.41 million |
| Total Assets | N/A | N/A | 291.31 million | 313.31 million | 337.99 million |
| Common Stock | 8000 | 8000 | 8000 | 8000 | 8000 |
| Other Current Assets | N/A | N/A | N/A | N/A | 3.78 million |
| Retained Earnings | -511.09 million | -494.48 million | -486.9 million | -467.49 million | -446.54 million |
| Other Liabilities | 167.61 million | 171.39 million | 172.48 million | 166.67 million | 173.94 million |
| Other Assets | 468000 | 468000 | 468000 | 468000 | 468000 |
| Cash | N/A | N/A | 59.62 million | 53.61 million | 79.56 million |
| Total Current Liabilities | N/A | N/A | 21.6 million | 32.48 million | 30.41 million |
| Other Stockholder Equity | 439000 | -140000 | 414000 | -178000 | 1.04 million |
| Property, Plant & Equipment | 42.04 million | 43.21 million | 45.8 million | 46.88 million | 47.79 million |
| Total Current Assets | N/A | N/A | 217.9 million | 235.81 million | 256.78 million |
| Long Term Investments | N/A | 3.01 million | N/A | 3.59 million | N/A |
| Net Tangible Assets | 19.72 million | 33.09 million | 38.45 million | 55.49 million | 68.09 million |
| Short Term Investments | N/A | 108.54 million | 153.98 million | 178.18 million | 172.07 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | 752000 | 414000 | 1.64 million | 1000000 |
Aduro Biotech, Inc (ADRO) Chart:
Aduro Biotech, Inc (ADRO) News:
Below you will find a list of latest news for Aduro Biotech, Inc (ADRO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aduro Biotech, Inc (ADRO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Aduro Biotech, Inc (ADRO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520186909/0001193125-20-186909-index.htm |
| 2020-08-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1435049/000000000020007103/0000000000-20-007103-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000021545719006546/0000215457-19-006546-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000083423720004835/0000834237-20-004835-index.htm |
| 2019-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000090221919000002/0000902219-19-000002-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000090221919000022/0000902219-19-000022-index.htm |
| 2019-01-22 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000090445419000071/0000904454-19-000071-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000103738920000091/0001037389-20-000091-index.htm |
| 2020-02-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000108887520000052/0001088875-20-000052-index.htm |
| 2019-03-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1435049/000110465919016796/0001104659-19-016796-index.htm |
| 2019-05-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1435049/000110465919031739/0001104659-19-031739-index.htm |
| 2019-01-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000117031619000003/0001170316-19-000003-index.htm |
| 2020-01-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000117031620000001/0001170316-20-000001-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312518289503/0001193125-18-289503-index.htm |
| 2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312518323130/0001193125-18-323130-index.htm |
| 2018-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312518352108/0001193125-18-352108-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312519003027/0001193125-19-003027-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000119312519032219/0001193125-19-032219-index.htm |
| 2019-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312519046243/0001193125-19-046243-index.htm |
| 2019-02-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1435049/000119312519054130/0001193125-19-054130-index.htm |
| 2019-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1435049/000119312519054155/0001193125-19-054155-index.htm |
| 2019-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312519188230/0001193125-19-188230-index.htm |
| 2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312519257413/0001193125-19-257413-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312519316251/0001193125-19-316251-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520004963/0001193125-20-004963-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520005777/0001193125-20-005777-index.htm |
| 2020-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520013145/0001193125-20-013145-index.htm |
| 2020-03-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1435049/000119312520067262/0001193125-20-067262-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520157987/0001193125-20-157987-index.htm |
| 2020-06-02 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520157988/0001193125-20-157988-index.htm |
| 2020-06-02 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520158646/0001193125-20-158646-index.htm |
| 2020-06-02 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520158648/0001193125-20-158648-index.htm |
| 2020-06-02 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520158652/0001193125-20-158652-index.htm |
| 2020-06-03 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520158933/0001193125-20-158933-index.htm |
| 2020-06-05 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520160920/0001193125-20-160920-index.htm |
| 2020-06-10 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520165702/0001193125-20-165702-index.htm |
| 2020-06-10 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520165706/0001193125-20-165706-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520186906/0001193125-20-186906-index.htm |
| 2020-07-02 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520186909/0001193125-20-186909-index.htm |
| 2020-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520194724/0001193125-20-194724-index.htm |
| 2020-07-22 | S-4 | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520196554/0001193125-20-196554-index.htm |
| 2020-08-03 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520208115/0001193125-20-208115-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520223665/0001193125-20-223665-index.htm |
| 2020-08-18 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520223670/0001193125-20-223670-index.htm |
| 2020-08-18 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520223674/0001193125-20-223674-index.htm |
| 2020-08-24 | S-4/A | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520227443/0001193125-20-227443-index.htm |
| 2020-08-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1435049/000119312520227456/0001193125-20-227456-index.htm |
| 2020-08-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1435049/000119312520227491/0001193125-20-227491-index.htm |
| 2020-08-26 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1435049/000119312520231238/0001193125-20-231238-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520236282/0001193125-20-236282-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520249542/0001193125-20-249542-index.htm |
| 2020-09-21 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520249551/0001193125-20-249551-index.htm |
| 2020-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520252523/0001193125-20-252523-index.htm |
| 2020-09-24 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1435049/000119312520252525/0001193125-20-252525-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520261293/0001193125-20-261293-index.htm |
| 2020-10-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1435049/000119312520264856/0001193125-20-264856-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520265606/0001193125-20-265606-index.htm |
| 2020-10-15 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1435049/000119312520270350/0001193125-20-270350-index.htm |
| 2020-11-05 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000119312520286962/0001193125-20-286962-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054231/0001209191-20-054231-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054232/0001209191-20-054232-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054233/0001209191-20-054233-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054234/0001209191-20-054234-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054236/0001209191-20-054236-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054237/0001209191-20-054237-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054238/0001209191-20-054238-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054241/0001209191-20-054241-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054242/0001209191-20-054242-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054244/0001209191-20-054244-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/0001209191-20-054245-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054246/0001209191-20-054246-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054247/0001209191-20-054247-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054249/0001209191-20-054249-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054250/0001209191-20-054250-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054251/0001209191-20-054251-index.htm |
| 2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054252/0001209191-20-054252-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054253/0001209191-20-054253-index.htm |
| 2020-06-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1435049/000121390020014723/0001213900-20-014723-index.htm |
| 2019-03-29 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000155837019002631/0001558370-19-002631-index.htm |
| 2019-03-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1435049/000155837019002636/0001558370-19-002636-index.htm |
| 2019-03-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1435049/000155837019002638/0001558370-19-002638-index.htm |
| 2019-04-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000155837019003083/0001558370-19-003083-index.htm |
| 2019-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1435049/000155837019003085/0001558370-19-003085-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000155837019004266/0001558370-19-004266-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000155837019005082/0001558370-19-005082-index.htm |
| 2018-10-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459018025616/0001564590-18-025616-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459018025624/0001564590-18-025624-index.htm |
| 2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1435049/000156459019004942/0001564590-19-004942-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459019004945/0001564590-19-004945-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459019016502/0001564590-19-016502-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459019016517/0001564590-19-016517-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459019027956/0001564590-19-027956-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459019027964/0001564590-19-027964-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459019041741/0001564590-19-041741-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459019041752/0001564590-19-041752-index.htm |
| 2020-03-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1435049/000156459020009364/0001564590-20-009364-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459020009368/0001564590-20-009368-index.htm |
| 2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459020012521/0001564590-20-012521-index.htm |
| 2020-03-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1435049/000156459020012526/0001564590-20-012526-index.htm |
| 2020-03-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1435049/000156459020012532/0001564590-20-012532-index.htm |
| 2020-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459020016116/0001564590-20-016116-index.htm |
| 2020-05-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459020020832/0001564590-20-020832-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459020020835/0001564590-20-020835-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459020021942/0001564590-20-021942-index.htm |
| 2020-08-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459020035508/0001564590-20-035508-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1435049/000156459020035522/0001564590-20-035522-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1435049/000156459020051403/0001564590-20-051403-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002681/0001567619-18-002681-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002682/0001567619-18-002682-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002683/0001567619-18-002683-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002684/0001567619-18-002684-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918003109/0001567619-18-003109-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918003110/0001567619-18-003110-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918006813/0001567619-18-006813-index.htm |
| 2018-12-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918007494/0001567619-18-007494-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008011/0001567619-18-008011-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008013/0001567619-18-008013-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008014/0001567619-18-008014-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008015/0001567619-18-008015-index.htm |
| 2018-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008822/0001567619-18-008822-index.htm |
| 2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919002649/0001567619-19-002649-index.htm |
| 2019-02-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005094/0001567619-19-005094-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005097/0001567619-19-005097-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005099/0001567619-19-005099-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005101/0001567619-19-005101-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005105/0001567619-19-005105-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005106/0001567619-19-005106-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005107/0001567619-19-005107-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005538/0001567619-19-005538-index.htm |
| 2019-03-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919007394/0001567619-19-007394-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-04-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008984/0001567619-19-008984-index.htm |
| 2019-04-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008985/0001567619-19-008985-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm |
| 2019-05-08 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919010193/0001567619-19-010193-index.htm |
| 2019-05-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011350/0001567619-19-011350-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011351/0001567619-19-011351-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011352/0001567619-19-011352-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011354/0001567619-19-011354-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011355/0001567619-19-011355-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011356/0001567619-19-011356-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011358/0001567619-19-011358-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011359/0001567619-19-011359-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011878/0001567619-19-011878-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919014112/0001567619-19-014112-index.htm |
| 2019-07-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919014788/0001567619-19-014788-index.htm |
| 2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919014789/0001567619-19-014789-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018455/0001567619-19-018455-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018456/0001567619-19-018456-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018457/0001567619-19-018457-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018458/0001567619-19-018458-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023141/0001567619-19-023141-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023142/0001567619-19-023142-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023144/0001567619-19-023144-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023145/0001567619-19-023145-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920000643/0001567619-20-000643-index.htm |
| 2020-01-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920001689/0001567619-20-001689-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004744/0001567619-20-004744-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004745/0001567619-20-004745-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004746/0001567619-20-004746-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004747/0001567619-20-004747-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004748/0001567619-20-004748-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004749/0001567619-20-004749-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004897/0001567619-20-004897-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920006851/0001567619-20-006851-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920006852/0001567619-20-006852-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011285/0001567619-20-011285-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011286/0001567619-20-011286-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011287/0001567619-20-011287-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011288/0001567619-20-011288-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011289/0001567619-20-011289-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011290/0001567619-20-011290-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011634/0001567619-20-011634-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011635/0001567619-20-011635-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011637/0001567619-20-011637-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011638/0001567619-20-011638-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011639/0001567619-20-011639-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920014727/0001567619-20-014727-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920014728/0001567619-20-014728-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920014729/0001567619-20-014729-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920016852/0001567619-20-016852-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920016853/0001567619-20-016853-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1435049/000156761920016854/0001567619-20-016854-index.htm |
| 2020-08-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1435049/999999999520002260/9999999995-20-002260-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1435049/999999999719001432/9999999997-19-001432-index.htm |
Aduro Biotech, Inc (ADRO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aduro Biotech, Inc (ADRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2984%Institutional Ownership: 4476%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-01 | William G Kachioff | Interim CFO | Buy | 10,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011639/0001567619-20-011639-index.htm | ||
| 2019-09-13 | Blaine Templeman | Chief Legal Officer | Sell | 5,888.00 | 1.31 | 7,689.14 | 117,000.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018455/0001567619-19-018455-index.htm |
| 2019-12-12 | Blaine Templeman | Chief Legal Officer | Sell | 1,264.00 | 1.16 | 1,470.41 | 117,736.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023145/0001567619-19-023145-index.htm |
| 2020-06-01 | Dimitry SA Nuyten | Chief Medical Officer | Buy | 10,000.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011635/0001567619-20-011635-index.htm | ||
| 2020-06-01 | Ross Haghighat | Director | Buy | 34,124.00 | 121,246.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011637/0001567619-20-011637-index.htm | ||
| 2020-09-15 | Blaine Templeman | Chief Legal Officer | Sell | 12,369.00 | 2.39 | 29,585.41 | 121,916.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920016853/0001567619-20-016853-index.htm |
| 2019-09-13 | Blaine Templeman | Chief Legal Officer | Sell | 6,990.00 | 1.31 | 9,127.54 | 122,888.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018455/0001567619-19-018455-index.htm |
| 2018-12-12 | Blaine Templeman | Chief Legal Officer | Sell | 1,241.00 | 2.93 | 3,638.61 | 129,878.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008014/0001567619-18-008014-index.htm |
| 2018-09-24 | Blaine Templeman | Chief Legal Officer | Sell | 10,262.00 | 5.81 | 59,612.98 | 131,119.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918003109/0001567619-18-003109-index.htm |
| 2018-11-20 | Blaine Templeman | Chief Legal Officer | Sell | 843.00 | 2.91 | 2,452.54 | 131,119.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918006813/0001567619-18-006813-index.htm |
| 2020-08-07 | Blaine Templeman | Chief Legal Officer | Sell | 7,951.00 | 2.55 | 20,307.65 | 134,285.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920014728/0001567619-20-014728-index.htm |
| 2018-12-12 | Jennifer Lew | Chief Financial Officer | Sell | 1,035.00 | 2.93 | 3,034.62 | 135,155.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008015/0001567619-18-008015-index.htm |
| 2019-04-08 | Jennifer Lew | Chief Financial Officer | Sell | 2,232.00 | 4.07 | 9,087.14 | 135,155.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-04-08 | Jennifer Lew | Chief Financial Officer | Sell | 12,144.00 | 4.07 | 49,468.58 | 135,155.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-04-08 | Jennifer Lew | Chief Financial Officer | Sell | 4,225.00 | 4.08 | 17,219.41 | 135,155.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-05-01 | Jennifer Lew | Chief Financial Officer | Sell | 4,226.00 | 4.20 | 17,750.89 | 135,155.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm |
| 2018-09-13 | Jennifer Lew | Chief Financial Officer | Sell | 5,623.00 | 6.50 | 36,545.56 | 136,190.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002682/0001567619-18-002682-index.htm |
| 2019-04-08 | Jennifer Lew | Chief Financial Officer | Buy | 2,232.00 | 1.00 | 2,232.00 | 137,387.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-05-01 | Jennifer Lew | Chief Financial Officer | Buy | 2,232.00 | 1.00 | 2,232.00 | 137,387.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm |
| 2019-04-08 | Jennifer Lew | Chief Financial Officer | Buy | 4,225.00 | 0.82 | 3,464.50 | 139,380.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-05-01 | Jennifer Lew | Chief Financial Officer | Buy | 4,226.00 | 0.82 | 3,465.32 | 139,381.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm |
| 2018-09-13 | Blaine Templeman | Executive VP, General Counsel | Sell | 6,056.00 | 6.50 | 39,359.76 | 141,381.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002684/0001567619-18-002684-index.htm |
| 2018-09-12 | Jennifer Lew | Chief Financial Officer | Buy | 67,825.00 | 141,813.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002682/0001567619-18-002682-index.htm | ||
| 2020-06-01 | Blaine Templeman | Chief Legal Officer | Buy | 22,500.00 | 142,236.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011634/0001567619-20-011634-index.htm | ||
| 2019-04-08 | Jennifer Lew | Chief Financial Officer | Buy | 12,144.00 | 1.45 | 17,608.80 | 147,299.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm |
| 2019-05-01 | Jennifer Lew | Chief Financial Officer | Buy | 12,144.00 | 1.45 | 17,608.80 | 147,299.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm |
| 2018-09-12 | Blaine Templeman | Executive VP, General Counsel | Buy | 77,500.00 | 147,437.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002684/0001567619-18-002684-index.htm | ||
| 2020-10-05 | Tom Frohlich | Chief Business Officer | Buy | 153,398.00 | 153,398.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054246/0001209191-20-054246-index.htm | ||
| 2018-09-13 | Natalie Sacks | Chief Medical Officer | Sell | 3,028.00 | 6.50 | 19,679.88 | 173,720.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002681/0001567619-18-002681-index.htm |
| 2018-09-12 | Natalie Sacks | Chief Medical Officer | Buy | 87,200.00 | 176,748.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002681/0001567619-18-002681-index.htm | ||
| 2020-03-18 | William Mariner Greenman | Director | Buy | 19,835.00 | 0.45 | 8,925.75 | 19,835.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920006852/0001567619-20-006852-index.htm |
| 2019-03-19 | Elsas Andrea van | Chief Scientific Officer | Sell | 6,081.00 | 3.96 | 24,106.91 | 239,557.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919007394/0001567619-19-007394-index.htm |
| 2020-10-05 | Davis Jerel | Director | Buy | 2,433,099.00 | 2,433,099.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm | ||
| 2019-02-26 | Elsas Andrea van | Chief Scientific Officer | Sell | 6,844.00 | 4.25 | 29,119.85 | 245,638.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919005538/0001567619-19-005538-index.htm |
| 2018-12-28 | Elsas Andrea van | Chief Scientific Officer | Sell | 1,907.00 | 2.57 | 4,900.99 | 252,482.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008822/0001567619-18-008822-index.htm |
| 2018-12-12 | Elsas Andrea van | Chief Scientific Officer | Sell | 2,171.00 | 2.93 | 6,365.37 | 254,389.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008011/0001567619-18-008011-index.htm |
| 2018-09-24 | Elsas Andrea van | Chief Scientific Officer | Sell | 7,726.00 | 5.83 | 45,021.72 | 256,560.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918003110/0001567619-18-003110-index.htm |
| 2018-09-13 | Elsas Andrea van | Chief Scientific Officer | Sell | 9,754.00 | 6.50 | 63,394.17 | 264,286.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002683/0001567619-18-002683-index.htm |
| 2019-12-12 | Celeste Ferber | SVP, GC and Secretary | Sell | 408.00 | 1.16 | 474.63 | 26,534.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023144/0001567619-19-023144-index.htm |
| 2019-09-13 | Celeste Ferber | SVP, GC and Secretary | Sell | 1,102.00 | 1.31 | 1,439.32 | 26,942.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018458/0001567619-19-018458-index.htm |
| 2018-09-12 | Elsas Andrea van | Chief Scientific Officer | Buy | 67,825.00 | 274,040.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918002683/0001567619-18-002683-index.htm | ||
| 2020-09-15 | STEPHEN T ISAACS | President and CEO | Sell | 32,481.00 | 2.39 | 77,691.30 | 279,166.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920016854/0001567619-20-016854-index.htm |
| 2019-09-13 | Celeste Ferber | SVP, GC and Secretary | Sell | 1,392.00 | 1.31 | 1,817.81 | 28,044.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018458/0001567619-19-018458-index.htm |
| 2019-12-12 | STEPHEN T ISAACS | President and CEO | Sell | 5,897.00 | 1.16 | 6,859.98 | 290,029.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023141/0001567619-19-023141-index.htm |
| 2019-05-20 | Celeste Ferber | SVP, GC and Secretary | Sell | 2,000.00 | 3.21 | 6,413.00 | 29,436.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919011878/0001567619-19-011878-index.htm |
| 2019-09-13 | STEPHEN T ISAACS | President and CEO | Sell | 31,098.00 | 1.31 | 40,607.77 | 295,926.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018457/0001567619-19-018457-index.htm |
| 2020-03-18 | STEPHEN T ISAACS | President and CEO | Sell | 21,618.00 | 0.45 | 9,728.10 | 311,647.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920006851/0001567619-20-006851-index.htm |
| 2020-10-05 | SRINIVAS AKKARAJU | Director | Buy | 3,168,388.00 | 3,168,388.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054251/0001209191-20-054251-index.htm | ||
| 2018-12-12 | STEPHEN T ISAACS | President and CEO | Sell | 5,829.00 | 2.93 | 17,090.63 | 327,024.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761918008013/0001567619-18-008013-index.htm |
| 2020-09-15 | Celeste Ferber | SVP, GC and Secretary | Sell | 2,396.00 | 2.39 | 5,730.99 | 38,687.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920016852/0001567619-20-016852-index.htm |
| 2020-08-07 | Celeste Ferber | SVP, GC and Secretary | Sell | 7,951.00 | 2.55 | 20,307.65 | 41,083.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920014727/0001567619-20-014727-index.htm |
| 2020-02-25 | Elsas Andrea van | Chief Scientific Officer | Sell | 6,823.00 | 3.51 | 23,953.51 | 438,367.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920004897/0001567619-20-004897-index.htm |
| 2020-01-03 | Elsas Andrea van | Chief Scientific Officer | Sell | 73,311.00 | 1.19 | 87,108.13 | 445,190.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920000643/0001567619-20-000643-index.htm |
| 2020-10-05 | ERIC DOBMEIER | President, CEO | Buy | 46,337.00 | 46,337.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/0001209191-20-054245-index.htm | ||
| 2020-10-05 | Davis Jerel | Director | Buy | 4,733,023.00 | 4,733,023.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm | ||
| 2020-06-01 | Celeste Ferber | SVP, GC and Secretary | Buy | 22,500.00 | 49,034.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920011638/0001567619-20-011638-index.htm | ||
| 2019-09-16 | Ross Haghighat | Director | Buy | 18,000.00 | 1.00 | 18,000.00 | 49,583.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm |
| 2019-12-12 | Elsas Andrea van | Chief Scientific Officer | Sell | 2,192.00 | 1.16 | 2,549.95 | 518,501.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919023142/0001567619-19-023142-index.htm |
| 2019-09-13 | Elsas Andrea van | Chief Scientific Officer | Sell | 634.00 | 1.31 | 828.07 | 520,693.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018456/0001567619-19-018456-index.htm |
| 2019-09-13 | Elsas Andrea van | Chief Scientific Officer | Sell | 17,959.00 | 1.31 | 23,450.86 | 521,327.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018456/0001567619-19-018456-index.htm |
| 2019-06-26 | Elsas Andrea van | Chief Scientific Officer | Buy | 275,000.00 | 539,286.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919014112/0001567619-19-014112-index.htm | ||
| 2019-09-16 | Ross Haghighat | Director | Buy | 21,451.00 | 0.45 | 9,652.95 | 71,034.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm |
| 2020-10-05 | Davis Jerel | Director | Buy | 722,247.00 | 722,247.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm | ||
| 2020-10-05 | Davis Jerel | Director | Buy | 730,470.00 | 730,470.00 | https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm | ||
| 2019-09-16 | Ross Haghighat | Director | Buy | 4,566.00 | 0.45 | 2,054.70 | 75,600.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm |
| 2019-09-16 | Ross Haghighat | Director | Buy | 2,459.00 | 0.45 | 1,106.55 | 78,059.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm |
| 2020-08-07 | Dimitry SA Nuyten | Chief Medical Officer | Sell | 3,538.00 | 2.55 | 9,036.41 | 8,462.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761920014729/0001567619-20-014729-index.htm |
| 2019-09-16 | Ross Haghighat | Director | Buy | 9,063.00 | 0.52 | 4,712.76 | 87,122.00 | https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm |